Staph Aureus
Vaccine

Clinical Trial

Why are we doing this trial?

This clinical study is to evaluate an investigational vaccine that may provide protection against skin and soft tissue infections caused by Staphylococcus aureus.

This bacterium has the highest antibiotic resistance and currently no vaccine is available on the market. You may be eligible to participate in this study if you have had a recent Staphylococcus aureus skin or soft tissue infection.

We are currently recruiting new Clinical Trial participants.

So what are we looking for?

Our criteria is very simple

- 18-64 year olds with a recent or ongoing Staphylococcus aureus skin infection.

- Participants should not have any history of serious chronic or progressive disease

Do an online questionnaire to see if you qualify

Why you should consider being involved

We are testing a Staphylococcus aureus vaccine that may prevent staphylococcal infections, including those causes by antibiotic resistance MRSA (Methicillin-resistant staphylococcus). There is currently no vaccine available.

There is a high medical need worldwide for a vaccine against Staphylococcus aureus skin infections. This is your chance to be involved in a global study in this leading edge medicine.

This Clinical Trial is delivered by Middlemore Clinical Trials (Te Kohinga Ora)
a well known & respected health organisation, based at Middlemore Hospital.

See participants information on the Middlemore Clinical Trial website

Register your interest in participating

By filling in this form you are simply inviting a Middlemore Clinical Trials Research Nurse to contact you and discuss your suitability to participate. It will also allow you to ask any questions you might have about this trial, your obligations, and of course any concerns you may have about participating.

One of our team will be in contact within 24 hours (weekdays only) to provide you with more detail.